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Background: Self-management interventions (SMIs) are recommended for individuals with 
COPD to help monitor symptoms and optimize health-related quality of life (HRQOL). How-
ever, SMIs vary widely in content, delivery, and intensity, making it unclear which methods 
and techniques are associated with improved outcomes. This systematic review aimed to sum-
marize the current evidence base surrounding the effectiveness of SMIs for improving HRQOL 
in people with COPD.
Methods: Systematic reviews that focused upon SMIs were eligible for inclusion. Intervention 
descriptions were coded for behavior change techniques (BCTs) that targeted self-management 
behaviors to address 1) symptoms, 2) physical activity, and 3) mental health. Meta-analyses 
and meta-regression were used to explore the association between health behaviors targeted 
by SMIs, the BCTs used, patient illness severity, and modes of delivery, with the impact on 
HRQOL and emergency department (ED) visits.
Results: Data related to SMI content were extracted from 26 randomized controlled trials 
identified from 11 systematic reviews. Patients receiving SMIs reported improved HRQOL 
(standardized mean difference =-0.16; 95% confidence interval [CI] =-0.25, -0.07; P=0.001) 
and made fewer ED visits (standardized mean difference =-0.13; 95% CI =-0.23, -0.03; 
P=0.02) compared to patients who received usual care. Patients receiving SMIs targeting 
mental health alongside symptom management had greater improvement of HRQOL (Q=4.37; 
P=0.04) and fewer ED visits (Q=5.95; P=0.02) than patients receiving SMIs focused on 
symptom management alone. Within-group analyses showed that HRQOL was significantly 
improved in 1) studies with COPD patients with severe symptoms, 2) single-practitioner 
based SMIs but not SMIs delivered by a multidisciplinary team, 3) SMIs with multiple ses-
sions but not single session SMIs, and 4) both individual- and group-based SMIs.
Conclusion: SMIs can be effective at improving HRQOL and reducing ED visits, with those 
targeting mental health being significantly more effective than those targeting symptom man-
agement alone.
Keywords: self-management, emergency department visits, behavior change techniques, COPD, 
mental health, meta-analysis
Introduction
COPD is characterized by airflow limitation and is associated with inflammatory 
changes that lead to dyspnea, sputum purulence, and persistent coughing. The disease 
trajectory is one of progressive decline, punctuated by frequent acute exacerbations 
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in symptoms. Patients with COPD have an average of three 
acute exacerbations per year, and these are the second big-
gest cause of unplanned hospital admissions in the UK.1–3 
As COPD is irreversible, and health-related quality of life 
(HRQOL) in patients with COPD tends to be low, optimizing 
HRQOL and reducing hospital admissions have become key 
priorities in COPD management.4,5
Self-management planning is a recognized quality stan-
dard of the National Institute for Health and Care Excel-
lence (NICE) guidelines in the UK,2 and a joint statement 
by the American Thoracic Society/European Respiratory 
Society6 emphasized its importance in quality of care. 
Self-management interventions (SMIs) encourage patients 
to monitor symptoms when stable and to take appropriate 
action when symptoms begin to worsen.2 However, there is 
no consensus on the form and content of effective SMIs and 
the variation in content may explain previous heterogeneity 
in effectiveness.2,7,8 A recent Health Technology Assessment 
(HTA) report on the efficacy of self-management for COPD 
recommended that future research should 1) “try to identify 
which are the most effective components of interventions 
and identify patient-specific factors that may modify this”, 
and that 2) “behavior change theories and strategies that 
underpin COPD SMIs need to be better characterized and 
described”.8 To enable better comparison and replication of 
intervention components, taxonomies have been developed 
to classify potential active ingredients of interventions 
according to preestablished descriptions of behavior change 
techniques (BCTs).9 BCTs are defined as “an observable, 
replicable, and irreducible component of an intervention 
designed to alter or redirect causal processes that regulate 
behavior”.9 While recent reviews have conducted content 
analysis to help identify effective components of SMIs 
for patients with COPD through individual patient data 
analysis,10,11 the coding of intervention content was not 
performed with established taxonomies and clear under-
standing between the BCT and the targeted behavior was 
absent (eg, symptom management, physical activity, mental 
health management, etc).
This systematic review aims to summarize the cur-
rent evidence base on the effectiveness of SMIs for 
improving HRQOL in people with COPD. Conclusions 
across reviews have been synthesized and evaluated 
within the context of how self-management was defined. 
Meta-analyses were performed that explore the relation-
ship between health behaviors the SMIs target, the BCT 
they use to target behaviors, and subsequent improve-
ment in HRQOL and health care utilization. In addition, 
we explore the extent to which trial and intervention 
features influence SMI effects.
Method
Search strategy and selection criteria
The current review, registered with PROSPERO (CRD42 
016043311), is available at http://www.crd.york.ac.uk/
PROSPERO/display_record.asp?ID=CRD42016043311. 
To focus the search upon high-quality systematic reviews, 
we searched two databases of systematic reviews: Cochrane 
Database of Systematic Reviews (Wiley) issue 7 of 12 2016, 
Database of Abstracts of Reviews of Effects (Wiley) issue 
2 of 4 2015 (latest available). In addition, we searched Ovid 
MEDLINE® In-Process & Other Non-Indexed Citations 
and Ovid MEDLINE® 2015 with a systematic review filter 
available from CADTH.12 All search results were screened 
for title and abstract by one reviewer (JN), and 20% of the 
results were screened by a second reviewer (KH-M) to 
ensure comparability. Two reviewers screened the search 
results at the full paper review stage. The search strategy 
(ran up to October 1, 2016) combined database-specific 
thesaurus headings and keywords describing COPD and 
self-management:
 1. exp Pulmonary Disease, Chronic Obstructive
 2. emphysema$.tw.
 3. (chronic$ adj3 bronchiti$).tw.
 4. (obstruct$ adj3 (pulmonary or lung$ or bronch$ or 
respirat$)).tw.
 5. (COPD or COAD or COBD or AECB).tw.
 6. or/1-5
 7. exp Self Care/
 8. (self-manag$ or self manag$ or self-car$ or self car$ or 
self-administ$ or self administ$).tw.
 9. (patient$ adj3 (focus$ or participat$ or centr$ or center$ 
or empower$ or support$ or collaborat$ or co-operat$ 
or cooperat$)).tw.
 10. or/7-9
 11. 6 and 10.
The review approach provides an overview of existing 
systematic reviews and is particularly helpful where mul-
tiple systematic reviews have been conducted. A review 
also provides an opportunity to compare the summaries and 
findings of previous reviews. In the present review, both a 
meta-analysis and narrative synthesis were conducted. The 
narrative synthesis compared the overview of findings as 
presented by the original authors, whereas meta-analyses 
were conducted on data from individual studies presented 
within the reviews. These quantitative analyses are helpful 
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to determine the effectiveness of SM interventions and the 
factors that influence their effectiveness.
To be eligible for the narrative synthesis, reviews had to 
focus upon interventions that targeted self-management. We 
sought to explore variations in definitions of self-management 
used by previous authors, and thus reviews were eligible if 
they specified they focused on SMIs, irrespective of the 
definition they applied. Reviews that focused on SMIs in 
addition to other types of interventions (eg, pulmonary 
rehabilitation, supervised exercise programs) were only 
eligible if the SMIs could be clearly separated from the 
other interventions. Reviews of interventions delivered in 
primary, secondary, tertiary, outpatient, or community care 
were eligible.
To be eligible for the quantitative analyses, randomized 
controlled trials delivered in primary, secondary, tertiary, 
outpatient, or community care were eligible if they 1) targeted 
patients with COPD (diagnosed by either a clinician/health 
care practitioner and/or agreed spirometry criteria, ie, forced 
expiratory volume in 1 second (FEV
1
)/forced vital capacity 
(FVC) ,70%),13 2) compared the SMI to a comparison group 
that received usual care during the study period, and 3) had 
a measure of HRQOL as an outcome measure. Studies were 
excluded if they involved mixed disease populations where 
COPD patients could not be separated for analysis. Figure 1 
provides a PRISMA diagram of reviews, and the trials within 
reviews, eligible for inclusion.
Primary outcome
The primary outcome measure was HRQOL measured by 
the Saint George Respiratory Questionnaire (SGRQ). The 
SGRQ is a disease-specific instrument designed to measure 
impact on overall health, daily life, and perceived well-
being in patients with obstructive airways disease.14 The 
measure provides a total score and subdomain scores of 
symptoms (frequency and severity of symptoms), activities 
(activities that cause or are limited by breathlessness), and 
impacts (social functioning and psychological disturbances 
resulting from airways disease) and is the most frequently 
used disease-specific measure of HRQOL in this population 
Figure 1 PRISMA diagram of trials eligible for review data extraction.
Abbreviations: HRQOL, health-related quality of life; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RCT, randomized controlled trial.
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group.15 Where trials did not use the SGRQ, scores from 
alternative HRQOL measures were used; the Chronic 
Respiratory Disease Questionnaire (CRQ), Clinical COPD 
Questionnaire (CCQ), or Sickness Impact Profile (SIP).16–18 
We combined scores across different questionnaires for meta-
analyses, as total SGRQ, CRQ, CCQ, and SIP scores have 
been shown to correlate well and as subdomain constructs 
share conceptual similarity.19–22 Studies using alternative 
HRQOL measures were not eligible.
Classification of intervention content 
and intervention delivery features
The Behavior Change Techniques Taxonomy version 1 
(BCTTv1) was used to code the content of intervention 
descriptions.9 Intervention descriptions were separately 
coded for self-management behaviors that targeted 1) symp-
toms, 2) physical activity, and 3) mental health. For instance, 
the description “patients were instructed to set themselves 
a walking goal each day” would be coded as “goal setting 
(behavior)” only for “physical activity” and not “mental 
health self-management” or “symptoms self-management.” 
Consequently, it is important to use an outcome measure 
where changes in score reflect a change in these behaviors; 
and these three behaviors of symptoms, physical activity, and 
mental health directly map on to the three subdomains of the 
SGRQ (ie, Symptoms, Activities, and Impacts, respectively). 
Examples of symptom-specific behaviors may include 
teaching appropriate inhalation techniques or mucus-clearing 
techniques.2 In contrast, physical activity behaviors may be 
structured exercise programs, techniques on how to incorpo-
rate light activity into daily routine, or energy conservation 
techniques.2 Finally, mental health-focused behaviors may 
include trying to teach patients communication strategies 
to help communicate mental health concerns, distraction 
techniques, relaxation exercises, or stress counseling.2
To identify whether any features of the delivery of the 
intervention itself influenced effectiveness, interventions 
were coded for intervention provider (multidisciplinary 
team or single practitioner), intervention format (individual 
or group-based), and intervention length (single session 
or multiple session).23 The BCTs identified and interven-
tion features of delivery were coded independently by one 
reviewer (JN) and checked independently by another (KH-M) 
(κ=0.89; 95% CI =0.82, 0.96). To determine the length of 
an intervention, the end point was defined as the final time 
participants received intervention content from the interven-
tion provider. Intervention contacts solely for data collection 
or for following up on participants without new content 
were not classed as intervention sessions. To assess whether 
intervention effects depend on disease severity, studies were 
divided into those with patients with mean predicted FEV
1
 
score ,50% or $50% at baseline.13
Data relating to the number of COPD-related emergency 
department (ED) visits and/or hospital admissions were 
extracted from eligible studies, where reported, and used 
to see whether fewer ED visits were reported in patients 
receiving SMIs compared to patients receiving usual care. 
Subsequently, SMIs were divided between those with and 
without BCTs targeting mental health and physical activity 
in order to examine whether they had a difference in the 
size of their effect in comparison to patients who received 
usual care.
Data extraction and analysis
The original studies were sought for further data extraction, 
to supplement the information reported in the reviews. Data 
reported at the follow-up time point most closely following 
the end point of the intervention period were used for meta-
analyses. We decided to group patients across time points 
as patients with COPD have high mortality rates; of those 
patients who are admitted, 15% will die within 3 months,24 
25% will die within 1 year,2 and 50% within 5 years.25 
While prespecifying a follow-up time point limits the bias 
of treatment reactivity, we may be excluding patients with 
shorter survival, who may not necessary survive to a later 
time point, who are likely to be those most in need of inter-
ventions that improve HRQOL. Sensitivity analyses were 
performed for studies collecting outcome data at less than 
6 months and 6-month and 12-month follow-up to explore 
any potential heterogeneity in the overall analysis. Data 
from intention-to-treat analyses were used where reported. 
If two interventions were compared against a control group 
(eg, action plans vs education vs usual care), data from both 
intervention arms were included in the main comparison and 
the number of participants in the control group was halved 
for each comparison.26
Postintervention outcomes reported as mean and SD 
were used for analysis. Mean change scores were used if 
postintervention scores were unavailable. When mean and 
SD values were unavailable, missing data were imputed 
using the median instead of the mean and by estimating the 
SD from the standard error, confidence intervals (CIs), or 
interquartile range.26,27
Standardized mean differences (SMDs) with 95% CIs 
were calculated and pooled using a random effects model 
for all studies. Dichotomous and continuous outcomes were 
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merged using Comprehensive Meta-Analysis (CMA) soft-
ware (v2.2, Biostat; Englewood, NJ, USA) to produce SMDs 
for each study, which are equivalent to Cohen’s d. SMD 
values of at least 0.2, 0.5, and 0.8 are indicative of small, 
medium, and large effect sizes, respectively.28 Heterogene-
ity across studies was assessed using Cochran Q test and I2 
test statistics.26
Random effects subgroup analyses with Q statistic tests 
were conducted using CMA software. Univariate moderator 
analyses were conducted to compare effect size between SMIs 
with moderate/severe COPD, single/multiple sessions, and 
single/multiple practitioners. Univariate moderator analyses 
were also used to compare SMIs with/without BCTs targeting 
mental health self-management and physical activity to 
examine whether they differed in effect for the number of 
ED visits in comparison to patients receiving usual care. 
Random effects univariate meta-regression was conducted 
using CMA software to examine whether the number of 
BCTs coded across SMIs was predictive of effectiveness.
Results
Narrative synthesis
Eleven reviews were eligible for inclusion,7,10,11,29–36 covering 
66 clinical trials (Figure 1). The decision over whether to 
include three reviews warranted further discussion and the 
rationale for inclusion/exclusion is detailed in Supplementary 
material. Reviews varied widely in their definitions of 
self-management and the number of individual studies that 
met their inclusion criteria (Tables 1 and 2). Zwerink et al7 
reported a significant effect of SMIs on HRQOL but did state 
that “heterogeneity among interventions, study populations, 
follow-up time, and outcome measures makes it difficult 
to formulate clear recommendations regarding the most 
effective form and content of self-management in COPD”. 
Table 1 Definitions of “self-management” used across reviews
Review Self-management definition
Jonkman et al11 Interventions providing information … and including minimally two of the following components: 1) stimulation of 
sign/symptom monitoring; 2) education in problem-solving skills, ie, self-treatment of acute exacerbations and stress/
symptom management; 3) smoking cessation … 4) medical treatment adherence; 5) physical activity; or 6) improving 
dietary intake.
Jonkman et al10 In addition to education about the condition … two of the following components … : 1) stimulation of sign/symptom 
monitoring, 2) education in problem-solving skills (ie, managing acute exacerbations/symptoms, resource utilisation), … 
3) medication adherence, 4) physical activity, 5) dietary intake, and/or 6) smoking cessation.
Zwerink et al7 Interventions required an iterative interaction process between participant and health care provider, preferably goal 
formulation and feedback and two of the following: smoking cessation, self-recognition/self-treatment of exacerbations, 
exercise/physical activity component, dietary advice, medication advice, or coping with breathlessness. Participant education 
only intervention were excluded.
Adams et al29 education (giving information alone) and/or behavioral support (providing tools to modify behaviors) and/or motivational 
(linking specific goals for behavioral changes to clinical information)
Bourbeau32 Education program included training that integrated specific skills for patients to control their disease and live functional lives. 
Program could also include education about acute exacerbation recognition and action to be taken, as well as periodic home 
visits/telephone calls provided by a health professional
Blackstock and 
webster31
education focusing on changing health behaviors through knowledge, goal setting, and development of action plans. Needed at 
least one occasion where the participant(s) had face-to-face interaction with the health professional. education not delivered 
in a formal manner was considered usual care
Harrison et al33 Action plan involving symptom monitoring and medical management as well as education providing knowledge and information 
on decision-making. Must include two of following: self-efficacy, problem solving, resource utilization, collaboration, emotional 
management, role management, and goal setting. excluded action plans alone and supervised exercise training.
Monninkhof 
et al35
Could involve COPD education and/or self-treatment (action plan) guidelines. education included written material or 
structured verbal interaction with a health care provider, but as part of a programme to improve COPD knowledge and 
understanding. Self-treatment guidelines (action plan) were written plans for self-management of exacerbations.
walters et al36 Use of guidelines detailing self-initiated interventions (ie, changing medication regime, visiting GP/hospital), which were 
undertaken in response to alterations in the patients’ COPD (eg, increase in breathlessness, sputum). educational component 
permitted if duration was up to 1 hour. excluded broader self-management support interventions.
Majothi et al34 Included one or more components commonly included in self-management interventions, such as action plans, exercise, 
education, inhaler technique, bronchial hygiene and breathing techniques, stress management and relaxation, nutritional 
programs, patient empowerment, support groups, and telecare
Bentsen et al30 Self-management is defined as the individual’s ability to manage his/her symptoms, treatment, physical and psychosocial 
consequences, and lifestyle changes when living with a chronic condition
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Jonkman et al10 showed SMIs to improve HRQOL in COPD 
patients at 6 and 12 months but did not identify any com-
ponents of the SMIs that were associated with the interven-
tion. The more recent reviews had strict inclusion criteria 
and were smaller in size as a result.30,33,34,36 Harrison et al33 
and Majothi et al34 focused on hospitalized and recently 
discharged patients. Harrison et al33 did not find any signifi-
cant differences in total or domain scores for HRQOL. In 
contrast, Majothi et al et al34 did find a significant effect on 
total SGRQ, but stressed that this finding should be treated 
with caution due to variable follow-up assessments. Walters 
et al36 focused on more restrictive criteria for interventions 
that were action plans and found no significant effect on 
HRQOL. Bentsen et al30 were less clear in their definition of 
an SMI, and this may explain the smaller number of studies. 
The authors reported that the majority of studies showed a 
benefit on HRQOL, but no meta-analysis was performed.
Quantitative synthesis
Twenty-six eligible, unique trials provide data on 28 
intervention groups (Figure 1 and Table 3). In total, trials 
reported on 3,518 participants (1,827 intervention, 1,691 
control) for this analysis. Mean age of participants was 
65.6 (SD =1.6; range =45–89) years. The majority of par-
ticipants were male (72%). Characteristics of included trials 
are reported in their respective reviews (Table 2). Table 3 
details which specific BCTs were used in each SMI. Table 4 
displays which intervention features and target behaviors 
were used in each SMI. SMIs showed a significant but small 
positive effect in improving HRQOL scores over usual care 
(SMD =-0.16; 95% CI =-0.25, -0.07; P=0.001). Statistical 
heterogeneity was moderate but significant (I2=36.6%; 
P=0.03), suggesting the need for further moderator/
subgroup analyses (Table 5). When studies using measures 
other than the SGRQ (n=6) were excluded, SMIs contin-
ued to show a significant effect on improving HRQOL, 
which was of comparable effect size (SMD =-0.16; 95% 
CI =-0.26, -0.05; P=0.003). SMIs with 12-month follow-up 
(n=15) were significantly more effective than usual care 
(SMD =-0.16; 95% CI =-0.29, -0.03; P=0.02), but sig-
nificant heterogeneity existed between studies (I2=53.4%; 
P=0.008). In trials with 6-month follow-up (n=10), there 
was no significant difference in effect between SMIs and 
control group on HRQOL (SMD =-0.11; 95% CI =-0.27, 
0.04; P=0.14) and even heterogeneity between studies 
was not significant (I2=26.2%; P=0.20). In trials with 
a follow-up less than 6-month postintervention (n=7), 
SMIs were significantly more effective than usual care 
(SMD =-0.29; 95% CI =-0.48, -0.11; P=0.002) and there 
was no significant heterogeneity (I2=2.4%; P=0.41).
Intervention delivery features
In comparison to patients receiving usual care, there were 
no significant differences in effect size in between-group 
comparisons of 1) single session vs multiple session SMIs, 
2) SMIs delivered by a single practitioner vs multidisci-
plinary teams, 3) SMIs targeting patients with moderate vs 
severe symptoms, and 4) individual-based vs group-based 
SMIs (Table 5). However, within-group moderator analy-
sis showed 1) SMIs to be significantly effective in COPD 
patients with severe symptoms, whereas no significant 
effect was observed in studies that recruited patients with 
moderate symptoms; 2) significant improvement with SMIs 
delivered by a single practitioner, while no effect with 
multidisciplinary interventions; 3) no effect with single-
session SMIs, but significant improvement with SMIs 
with multiple sessions; and 4) significant improvement in 
HRQOL was observed in both individual and group-based 
SMIs (Table 5).
SMIs targeting mental health had a significantly greater 
effect size than SMIs not targeting mental health management 
(Q=4.37; k=28; P=0.04) (Table 5). Within-group analysis 
showed SMIs that did not target mental health had no signifi-
cant effect on HRQOL. There was no difference in effect size 
between SMIs targeting and not targeting physical activity, 
with both groups of SMIs showing significant improvement 
in improving HRQOL in comparison to usual care.
Intervention content
All interventions were coded for at least one BCT that 
targeted symptom management. Of these 24 interventions, 
five targeted solely symptom management (20.8%), three 
targeted management of mental health concerns (12.5%), 
eleven targeted physical activity (45.8%), and five targeted 
all three behaviors (20.8%). The number of interventions 
reporting BCTs that target each of the three behaviors is 
presented in Tables 3 and 4. Across interventions, a mean of 
eight BCTs per intervention was coded (SD =3; range =3–13), 
with a mean of five BCTs (SD =2; range =2–10) for symp-
tom management, one BCT (SD =1; range =0–4) for mental 
health management, and two BCTs (SD =3; range =0–10) 
for physical activity. For symptom management, the three 
most common BCTs reported were “instruction on how to 
perform a behavior” (n=23/24 trials; 95.8%), “information 
about health consequences” (n=21/24; 87.5%), and “action 
planning” (n=16/24; 66.7%). For physical activity, the three 
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Table 3 BCTs used across studies eligible in meta-analysis
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BCTs 
coded 

Symptom management
Instruction on how to perform a behavior 27
Information about health consequences 25
Action planning 19
Self-monitoring of outcome(s) of behavior 13
Body changes 9
Adding objects to the environment 9
Feedback on behavior 8
Social support (practical) 8
Pharmacological support 7
Reduce negative emotions 4
Demonstration of the behavior 3
Goal setting (behavior) 3
Social support (unspecified) 3
Information about social and 
environmental consequences
3
Behavioral practice-rehearsal 2
Monitoring of outcome(s) of behavior 
by others without feedback
1
Biofeedback 1
Problem solving 1
Discrepancy between current behavior 
and goal
1
Mental health management
Reduce negative emotions 7
Information about emotional consequences 7
Body changes 5
Monitoring of emotional consequences 5
Social support (unspecified) 3
Social support (emotional) 2
Monitoring of outcome(s) of behavior by 
others without feedback
1
Physical activity
Information about health consequences 12
Instruction on how to perform a behavior 10
Demonstration of the behavior 6
Behavioral practice-rehearsal 6
Goal setting (behavior) 5
Body changes 2
Self-monitoring of behavior 2
(Continued)
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Table 4 Intervention features and number of BCTs targeting different behaviors across SMIs
Intervention studies grouped 
by effect size
SMD P-value Number of BCTs targeted for each 
behavior
Intervention features (1= Yes)
Total Symptom Mental 
health
Physical 
activity
Group 
component
Multiple 
session
Single 
providera
Medium effect size (SMD $0.5)
Moullec 200861 -2.44 ,0.001 8 2 2 4 1 1 –
emery et al 199840; exercise -0.74 0.03 9 2 4 3 1 1 –
Koff et al 200955 -0.71 0.03 8 7 1 – – 1 1
Small effect size (0.5. SMD $0.2)
Kheirabadi 200860 -0.42 0.17 9 6 2 1 1 1 NR
Bucknall et al 201243 -0.36 0.05 15 12 3 – – 1 1
Bourbeau et al 200337 -0.35 0.02 15 7 2 6 – 1 1
wakabayashi et al 201152 -0.26 0.21 4 3 – 1 – 1 –
Ninot et al 201150 -0.24 0.46 9 4 – 5 1 1 1
Rice et al 201051 -0.23 0.02 13 8 4 1 NR 1 1
Khdour et al 200948 -0.20 0.21 11 9 – 2 – 1 1
Limited effect (SMD ,0.2)
Coultas 200546; MM -0.19 0.43 3 3 – – – 1 1
Coultas 200546 CM -0.18 0.45 3 3 – – – 1 1
Gallefoss et al 199939 -0.17 0.55 8 8 – – 1 1 –
Garcia-Aymerich et al 200741 -0.16 0.55 6 5 – 1 – 1 –
Trappenburg et al 201157 -0.14 0.35 8 7 – 1 – 1 1
Littlejohns et al 199144 -0.13 0.45 4 4 – – – 1 1
Rootmensen 200862 -0.12 0.45 6 6 – – – – 1
Hermiz et al 200247 -0.10 0.54 5 4 – 1 – – 1
McGeoch et al 200649 -0.09 0.58 7 5 – 2 – – 1
Fan et al 201254 -0.04 0.79 6 4 1 1 1 1 1
Bischoff et al 201253 -0.03 0.88 8 6 1 1 – 1 1
Faulkner 201059 -0.02 0.96 10 2 – 8 1 1 1
Monninkhof et al 200442 -0.02 0.90 12 5 – 7 1 1 –
Taylor et al 201256 -0.02 0.94 18 10 6 2 1 1 1
watson et al 199738 0.00 1.00 8 6 – 2 – – –
emery et al 199840; no exercise 0.04 0.91 6 2 4 – 1 1 –
Zwar et al 201258 0.06 0.54 5 4 – 1 – 1 –
wood-Baker et al 200645 0.21 0.25 3 3 – – – – –
Notes: aIntervention delivered by a single provider (of any profession) rather than multidisciplinary team. Bold values are statistically significant.
Abbreviations: BCT, behavior change technique; SMD, standardized mean difference; SMI, self-management intervention; MM, nurse-assisted medical management; CM, 
nurse-assisted collaborative management; NR, not reported.
Table 3 (Continued)
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Total 
BCTs 
coded 

Social support (unspecified) 1
Generalization of a target behavior 1
Problem solving 1
Adding objects to the environment 2
Self-monitoring of outcome(s) of behavior 1
Graded task 1
Abbreviations: BCT, behavior change technique; SMD, standardized mean differences; MM, nurse-assisted medical management; CM, nurse-assisted collaborative 
management.
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Table 5 SMD, 95% CIs for the effect of self-management interventions compared with control conditions on measures of health-
related quality of life, with measures of heterogeneity
Moderators Number of 
interventions
Number of participants within trials Measure of effect
Total Intervention Control SMD (95% CI) P-value
Overall effect 28 3,518 1,827 1,691 -0.16 (-0.25 to -0.07) 0.001
Severitya
Moderate 10 1,172 610 562 -0.12 (-0.28 to 0.03) 0.12
Severe 14 1,644 874 770 -0.21 (-0.35 to -0.08) 0.01
Between group 0.39
Model of careb
Single practitioner 17 2,297 1,204 1,093 -0.17 (-0.29 to -0.06) ,0.01
Multidisciplinary team 9 1,117 581 536 -0.10 (-0.27 to 0.07) 0.23
Between group 0.49
Duration of intervention
Single session 5 637 321 316 -0.03 (-0.23 to 0.17) 0.77
Multiple session 23 2,881 1,506 1,375 -0.19 (-0.29 to -0.09) ,0.001
Between group 0.17
Session format
Individual 17 2,301 1,182 1,119 -0.14 (-0.25 to -0.02) 0.02
Group 10 789 420 369 -0.20 (-0.39 to 0.01) 0.04
Between group 0.56
Mental health
Targeted 11 1,313 698 615 -0.27 (-0.41 to -0.13) ,0.001
Not targeted 17 2,205 1,129 1,076 -0.08 (-0.19 to 0.02) 0.12
Between group 0.04
Physical activity
Targeted 18 2,550 1,297 1,253 -0.17 (-0.28 to -0.05) ,0.01
Not targeted 10 968 530 438 -0.14 (-0.30 to -0.02) 0.08
Between group 0.83
Notes: The number of participants has now been added as additional columns. The number of trials will not always equal 28 as missing data in some studies. aSample were, 
at baseline, predominantly classified as severe according to GOLD criteria. Studies may not have actively recruited a severe sample. bIntervention was delivered by a single 
provider (of any profession) rather than multidisciplinary team. Bold values indicate significant values.
Abbreviations: CI, confidence interval; GOLD, Global Initiative for Chronic Obstructive Lung Disease; SMD, standardized mean difference.
most common BCTs reported were “instruction on how to 
perform a behavior” (n=11/16 trials; 68.8%), “goal setting 
(behavior)” (n=8/16; 50%), and “demonstration of the 
behavior” (n=8/16 trials; 50%). For management of mental 
health concerns, the three most common BCTs reported were 
strategies to “reduce negative emotions” (n=4/8 trials; 50%), 
“provide social support (unspecified)” (n=3/8 trials; 37.5%), 
and “monitoring of emotional consequences” (n=3/8 trials; 
37.5%). Sixty-six (70.9%) of the 93 BCTs in the BCTTv1 
were not coded in any intervention. There was no significant 
association between the number of BCTs used and interven-
tion effectiveness for improving HRQOL (β=-0.01; 95% 
CI =-0.04, 0.01; k=28; Q=1.75; P=0.19).
Health care use
Overall, patients who received SMIs had significantly fewer ED 
visits compared to those who received usual care (SMD =-0.13; 
95% CI =-0.23, -0.03; n=15; P=0.02). There was no significant 
heterogeneity in the sample (I2=19.4%; P=0.24). The significant 
effect of SMIs on the number of ED visits in patients who 
received SMIs remained when examining only studies with 
a 12-month follow-up (SMD =-0.17, 95% CI =-0.27, -0.07; 
n=12; P=0.001) with no significant heterogeneity (I2=10.4%; 
P=0.34). Of the three intervention groups that did not have a 
12-month follow-up, only one used a 3-month follow-up and 
the two were from the same study where a 6-month follow-up 
was used. Thus, meta-analyses were not performed for either 
3-month or 6-month follow-up time points.
Within-group analyses revealed patients receiving SMIs 
targeting mental health made significantly fewer ED visits 
compared to patients receiving usual care (SMD =-0.22; 
95% CI =-0.32, -0.11; k=5; P,0.001). No difference was 
observed in the number of ED visits between patients receiv-
ing SMIs not targeting mental health and patients receiv-
ing usual care (SMD =0.001; 95% CI =-0.14, 0.14; k=10 
P=0.99). This led to a significant between-group difference 
in effect between SMIs targeting mental health compared to 
SMIs not targeting mental health (Q=5.95; P=0.02).
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Patients receiving SMIs targeting physical activity 
made significantly fewer ED visits compared to those who 
received usual care (SMD =0.20; 95% CI =-0.31, -0.08; 
k=8; P=0.001). No difference was observed between patients 
receiving SMIs not targeting physical activity and usual 
care (SMD =-0.03; 95% CI =-0.18, 0.12; k=7; P=0.68). In 
comparison to usual care, there was no difference in effect 
between SMIs targeting and not targeting physical activity 
(Q=3.03; k=15; P=0.08).
Discussion
The meta-analysis showed SMIs were significantly more 
effective than usual care in improving HRQOL and reducing 
the number of ED visits in patients with COPD. In addition, 
moderator analyses provided specific detail of relevance for 
clinicians regarding the design, content, and implementation 
of intervention in practice. SMIs that specifically target mental 
health concerns alongside symptom management were signifi-
cantly more effective in improving HRQOL and reducing ED 
visits than SMIs that focus on symptom management alone. 
Within-group analyses showed that HRQOL was significantly 
improved in 1) studies with COPD patients with severe level of 
symptoms but not in patients with a moderate level of symptoms, 
2) single-practitioner based SMIs but not in SMIs delivered by a 
multidisciplinary team, 3) SMIs with multiple sessions but not 
in SMIs delivered in a single session, 4) both individual- and 
group-based interventions, and 5) SMIs that target physical 
activity. Our analysis also highlighted how different BCTs were 
utilized for the three different self-management behaviors.
Targeting of specific behaviors in self-management 
approaches may explain heterogeneity in effectiveness. Our 
review found SMIs that tackle mental health concerns are 
more effective than those aimed directly at respiratory health. 
Management of mental health problems is acknowledged 
as an important part of COPD care as comorbid mental 
health problems are common in COPD, with an estimated 
prevalence of 10%–42% for depression and 10%–60% for 
anxiety.63–66 However, fewer than 30% of treatment providers 
adhere to current guidance for management of anxiety and 
depression in COPD.67,68 The nature and direction of the 
relationship between mental health and respiratory symptoms 
in COPD are difficult to disentangle.69 Breathlessness may 
be a symptom of anxiety or COPD, and in turn, deteriorat-
ing respiratory health may trigger anxiety;64 and anxiety 
is associated with more frequent hospital admissions for 
exacerbations.69 It follows that SMIs targeting mental health 
have the potential to improve HRQOL. Overall, few of the 
identified SMIs contained BCTs that targeted mental health 
self-management, although the six SMIs with the highest 
effect sizes utilized BCTs that targeted mental health con-
cerns (Table 4). The most commonly reported BCT to aid 
management of mental health was input to “reduce negative 
emotions.” Interventions using this technique may improve 
patients’ self-efficacy for managing their symptoms, which 
could reduce the likelihood of attending ED’s at the onset 
of an exacerbation.70 Alternatively, addressing mental health 
management may have an indirect effect in preventing a 
deterioration in clinical status by an improvement in mood, 
leading to greater willingness to engage in other preventa-
tive behaviors (eg, increased physical activity, medication 
adherence, improved nutritional diet).71
In both moderator analysis and within-group analyses, 
SMIs targeting physical activity did not demonstrate a greater 
improvement in HRQOL compared with SMIs that did not 
target physical activity. It is surprising that the effect was 
not stronger, as patients engaging in increased physical 
activity are less likely to experience deterioration in physical 
condition and acute exacerbation.66,72 In contrast, physical 
deconditioning and inactivity may lead to faster deteriora-
tion in clinical status and increase the likelihood of hospital 
admission.64,66 Zwerink et al7 also reported no improved 
benefit in SMIs that targeted physical activity. Furthermore, 
Table 4 highlights the wide variability in BCTs that were used 
when targeting physical activity; with interventions ranging 
from individualized, structured, supervised sessions to edu-
cation on physical activity. It is important when reporting 
SMIs that target physical activity that authors are clear about 
what is being asked of the patient. The American Thoracic 
Society and European Respiratory Society’s joint summary 
identifies physical activity outcomes as a priority for future 
research.6 The summary states that determining the optimal 
level of instruction is a priority in design of future physical 
activity interventions (eg, how many sessions, over what time 
period, and what specific exercises). However, it is important 
to consider that an individually tailored approach is needed 
for patients with COPD where there is wide variability in 
capability and resources.
The most commonly identified BCTs varied for the three 
separate behaviors. Those coded for symptom management 
and physical activity were similar in that they used BCTs 
centered on information provision (eg, “Instruction on 
how to perform the behavior,” “Information about health 
consequences,” “Demonstration of the behavior”), whereas 
those coded for management of mental health concerns 
encourage more awareness and reflective thought processes 
(eg, “reduce negative emotions,” “monitoring of emotional 
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consequences”). It is possible that SMIs that targeted mental 
health management routinely displayed larger effect sizes as 
a consequence of the type of BCTs rather than the behavior 
targeted. Further research should attempt to disentangle the 
extent to which it is specific BCTs, or the behavior targeted, 
that is responsible for the intervention effect.
One recommendation from the recent HTA review on 
SMIs was that “Novel approaches to influence behavior 
change … should be explored”.8 Our approach identifies that 
vast majority of potential BCTs in the taxonomy were not 
identified across studies, suggesting opportunities for novel 
intervention content. For instance, it was apparent that while 
SMIs targeting mental health were more effective in improv-
ing HRQOL (eg, “reduce negative emotions”), the BCTs 
employed in these studies were not those recommended in 
current guidance as core strategies of self-management for 
COPD (eg, goal setting, problem solving, action planning).2,6 
Similarly, while action planning is seen as a key component 
of effective self-management,2,6–8 some theoretical models 
specify that action planning is not always sufficient for behav-
ior change and that problem solving is required to effectively 
maintain behavior change.71 As COPD is characterized by 
frequent relapses in the form of acute exacerbations, it was 
surprising that the BCT “problem solving” was only coded 
in two studies (Table 4). Future SMIs need to incorporate 
how to deal with problem solving as coping with the repeated 
occurrences of breathlessness and exacerbations (and the 
associated anxiety of these symptoms arising) is an inevitable 
predictor of HRQOL.72
Intervention providers should look at how they can deliver 
the core strategies of self-management (eg, goal setting, 
problem solving) in ways that work across multiple behaviors 
rather than feeling certain BCTs are only applicable to single 
behaviors (eg, action planning can only be used for symptom 
management but not when explaining physical activity). For 
instance, “body changes” referred to breathing/relaxation 
techniques. This was often used for a specific behavior, but 
patients may have better outcomes if they understand how 
breathing/relaxation techniques can be used for managing 
breathlessness, reducing stress, and improving lung capacity 
when physically active. Explaining how the same behavior 
can be applied across situations may also be a more under-
standable message for patients with poor health literacy, 
rather than them believing that certain behavioral techniques 
can only be applied in certain contexts, especially when 
elevated anxiety may impair cognitive processing of the most 
suitable course of action. Furthermore, from an implementa-
tion perspective, SMIs employing multidisciplinary teams for 
individual-based interventions did not confer any significant 
increase in effect size. This is an important finding for clinical 
practice as single practitioner and group-based interventions 
are potentially of lower cost as multiple patients can be seen 
in a single setting.73
An interesting finding from the narrative synthesis is 
that the number of eligible studies in Jonkman et al’s10,11 
reviews and Zwerink et al7 was approximately double the 
number found in the other reviews. The majority of addi-
tional studies in these reviews were recent publications. 
This may suggest that the use of SMIs has increased in less 
than a decade. However, further inspection of the defini-
tions highlight where disparities between previous reviews 
may exist. Walters et al36 only allowed single component 
(action plans) interventions and found no effect, whereas 
Zwerink et al7 and Jonkman et al10 both found a significant 
effect but stipulated that SMIs had to have at least two 
components (eg, action plans, symptom monitoring, physi-
cal activity component, etc.). This review highlights how 
the definition of SMI directly influences whether an effect 
is found on HRQOL.
A number of the reviews attempted to summarize com-
ponents of their contributing SMIs, but these were often 
limited in description and were often a mixture of BCTs 
(eg, problem solving, action planning) and target behaviors 
(eg, mental health, physical activity). Zwerink et al7 and 
Jonkman et al10 were the only reviews to conduct subgroup 
analyses to quantify what content of SMIs are most effective. 
Zwerink et al7 attempted to look at SMIs that did and did 
not utilize action plans, exercise programs, and behavioral 
components. However, the definitions for each of these three 
subgroup analyses were ambiguous: 1) action plans had to 
focus on symptom management, and thus excludes action 
planning techniques when the target behavior is physical 
or mental health, 2) focusing on only standardized exercise 
programs neglects the ways physical activity may be encour-
aged in everyday life (eg, energy conservation techniques), 
and 3) the authors themselves state that “behavioral compo-
nents” was “difficult to determine because of lack of detailed 
information”. Jonkman et al’s11 subgroup analyses were 
based on the absence/presence of clear BCTs: management 
of psychological aspects, goal setting skills, self-monitoring 
logs, and problem-solving skills. However the authors 
1) combined a number of chronic conditions (COPD, chronic 
heart failure, and Type 2 diabetes) and 2) did not differenti-
ate between the individual BCTs and the target behaviors. 
To build upon these authors’ previous work, we have used 
a standardized taxonomy with definitions for a wider array 
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of BCTs and been more specific about the behavior the BCT 
is targeting. This allows better comparison of intervention 
content across studies and a more robust basis for synthe-
sis. Ultimately, the increasing popularity and awareness of 
SMIs, but an increasing variation in definition, indicates a 
need for more structured guidance on what constitutes self-
management so that both practitioners and patients are aware 
of what the content of self-management entails.
Strengths and limitations
Comparing the findings across reviews highlights how the 
definition of self-management had a direct impact on the 
number of eligible studies and consequently the conclusions 
drawn. The difference in conclusions further highlights the 
need for more detailed content analysis. The current analysis 
extracted robust empirical data from across reviews and their 
contributing clinical trials to examine intervention content and 
structure to isolate what factors may be essential for improv-
ing patient outcomes. The use of a standardized taxonomy 
of definitions allowed comparisons of intervention content 
across studies and provided a robust basis for synthesis. Our 
approach also highlighted specific BCTs used in a range 
of contexts to enable more discernment between interven-
tion features and outcome effectiveness. We used a concise 
search strategy in order to identify individual trial data and 
perform novel forms of exploratory analysis that examined the 
effectiveness of individual intervention components. For this 
exploratory analysis, small and hard to find trials are unlikely 
to introduce components that do not occur in a range of other 
trials, and as such it is unnecessary to carry out an exhaustive 
search to identify all existing trials. However, it is important 
to stress that while we present a comprehensive summary 
of SMIs that have been reported in previous reviews, this 
review does not aim to present the most up-to-date evidence 
base as a number of more recent SMI trials will not have been 
captured in these reviews.
There are limitations to the study worth noting. The 
limited number of studies meant that single rather than 
multiple variables were entered into the moderator analyses. 
For example, we could compare single vs multiple session 
SMIs or individual vs group SMIs but could not examine 
combinations of the different variables in a multivariate 
analysis. Thus, while these univariate analyses can helpfully 
guide intervention development by highlighting potential 
associations, they should not be interpreted in an additive 
fashion. Furthermore, meta-regression findings do not imply 
causality, as factors entered into these analyses were not 
randomized groups in the analyses.
It was difficult to ascertain the intensity with which some 
BCTs were administered and the same BCT could be used 
with varying intensity, eg, the instructors could provide 
“Feedback on the behavior” on a daily or monthly basis. 
Ultimately, the utility of this secondary analysis is depen-
dent on the reporting of intervention content by authors. It 
is possible that some BCTs were present in interventions, 
but not described in sufficient detail to allow coding. While 
we coded intervention manuals where available, there is 
a need for more transparency in intervention content in 
future studies.
Conclusion
SMIs can improve HRQOL and reduce the number of ED 
visits for patients with COPD, but there is wide variability 
in effect. To be effective, future interventions should focus 
on tackling mental health concerns but need not entail mul-
tidisciplinary and individual-focused SMIs.
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Three reviews were discussed for eligibility. A review by 
Walters et al1 focused upon studies where the intervention 
could be defined as
[...] use of guidelines detailing self-initiated interven-
tions (eg, changing medication regime […]) which were 
undertaken in response to alterations in the state of the 
patients’ COPD (eg, increase in breathlessness) […]. An 
educational component was permitted if the duration was 
short, up to 1 hour.1
Action plans were explicitly described as a central com-
ponent in the definitions of self-management used by a 
number of the review authors,2–6 and as Walters et al’s1 
definition was comparable to many of the definitions of 
self-management interventions used by other authors, we 
considered this review eligible.
In contrast, the focus of Jolly et al’s review7 was “self-
management” interventions, but the number of interventions 
included far exceeded the number of studies commonly found 
in the other eligible reviews and many would not typically be 
considered self-management (eg, structured pulmonary reha-
bilitation programs). As it was not possible to identify those 
that were primarily self-management based, we excluded 
this review as it summarizes evidence of a wider array of 
interventions for chronic obstructive pulmonary disease than 
self-management interventions.
Jonkman et al8 highlighted relevant studies in the search, 
but the focus of the analysis was on an individual patient data 
analysis and as such the overall findings are not relevant to 
the current narrative.
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